The answer depends entirely on how you define the term, and that definitional question has driven one of the sharpest statistical disputes in modern biology. If “hermaphrodite” refers strictly to a person born with both ovarian and testicular tissue, the condition is extraordinarily rare, occurring in roughly 1 in 5,000 to 1 in 100,000 births depending on the population studied. If the term is broadened to include all variations of sex development where chromosomes, hormones, or anatomy do not follow the typical male or female pathway, estimates range from about 0.018% to 1.7% of all births. That hundred-fold gap between figures is not a rounding error; it reflects a genuine disagreement about which bodies count as “intersex.”
Where the 1.7% and the 0.018% Come From
The most widely cited statistic, that about 1.7% of people are born intersex, traces back to biologist Anne Fausto-Sterling’s work in the late 1990s and early 2000s. Her estimate cast a wide net, including chromosomal variations like Klinefelter syndrome and Turner syndrome, hormonal conditions like late-onset congenital adrenal hyperplasia, and cases of ambiguous genitalia. The logic was inclusive: if your body deviates from the strictly defined male or female developmental pathway at any level, that counts.
The pushback came from physician Leonard Sax, who argued that this figure sweeps in conditions most clinicians would never label as intersex. Late-onset adrenal hyperplasia, for instance, can cause mild excess hair growth in adult women but does not produce ambiguous genitalia at birth. People with Klinefelter syndrome (who carry an extra X chromosome) are typically raised as boys, go through male puberty, and often never learn about their chromosomal difference until they have trouble conceiving. Sax proposed that “intersex” should be restricted to conditions where chromosomal sex is inconsistent with the body’s visible sex, or where the external anatomy cannot readily be classified as male or female. Under that tighter definition, the prevalence drops to about 0.018%, nearly a hundred times lower than Fausto-Sterling’s number.1PubMed. How common is intersex? a response to Anne Fausto-Sterling
Neither figure is “wrong” in a factual sense. They are answers to different questions. The 1.7% answers “how many people have some measurable variation in chromosomal, gonadal, or hormonal sex development?” The 0.018% answers “how many people are born with genitalia ambiguous enough that a clinician would flag it at birth?” Most news articles and advocacy materials cite the higher number; most clinical endocrinology references use something closer to the lower one.
Ovotesticular DSD, the Closest Thing to “True Hermaphroditism”
In older medical literature, the word “hermaphrodite” specifically meant a person with both ovarian and testicular tissue in their body. This condition now goes by ovotesticular disorder of sex development, or ovotesticular DSD. It is genuinely rare. Estimates vary, but it accounts for fewer than 10% of all DSD cases, which themselves are uncommon. In a Chinese series of 16 patients evaluated over many years at one center, the majority had a 46,XX karyotype, meaning their chromosomes looked typically female even though they developed both types of gonadal tissue.2PubMed Central. Evaluation and treatment for ovotesticular disorder of sex development (OT-DSD) – experience based on a Chinese series A few had mixed chromosome patterns. The condition arises when the genetic signals that push an early embryo toward ovary development or testis development get mixed, producing an ovotestis (a gonad containing both egg-producing and sperm-producing tissue) or one ovary and one testis on opposite sides.
People with ovotesticular DSD sometimes have ambiguous genitalia at birth, sometimes appear more typically male, and sometimes appear more typically female. The diagnosis usually requires a tissue biopsy of the gonad because external appearance alone cannot confirm the presence of both tissue types. The extreme rarity of this condition is worth emphasizing: when people casually ask “how rare is a hermaphrodite,” this is the condition they usually picture, and it is far rarer than the broader 1-in-60 figure might suggest.
How Sex Development Can Diverge
To understand why so many different conditions get lumped together, it helps to know that sex development is a cascade with multiple steps, and a variation at any step produces a different outcome. Early in embryonic development, the gonads are bipotential: they can become ovaries or testes. In typical male development, a gene called SRY on the Y chromosome triggers a chain of signals, activating other genes like SOX9, which steer the gonad toward becoming a testis.3PubMed. SRY, SOX9, and DAX1 expression patterns during human sex determination and gonadal development In typical female development, a different signaling pathway involving RSPO1 and WNT4 promotes ovarian differentiation.4PubMed. R-spondin1, WNT4, and the CTNNB1 signaling pathway: strict control over ovarian differentiation
A disruption at the chromosomal level (an extra or missing sex chromosome), at the gene level (a mutation in SRY or SOX9), at the hormonal level (the body cannot produce or respond to testosterone), or at the enzyme level (a missing enzyme prevents the conversion of one hormone to another) can each produce a different variation. This is why the umbrella category of differences of sex development includes such a wide range of presentations, from conditions that are invisible without genetic testing to conditions that are apparent in the delivery room.
Sex Chromosome Variations and Why They Skew the Numbers
The single biggest driver of the gap between the 1.7% and 0.018% figures is whether you count sex chromosome aneuploidies, conditions where a person has more or fewer sex chromosomes than the typical two. The overall rate of sex chromosome aneuploidies is roughly 1 in 500 live births.5PubMed Central. Sex chromosome aneuploidies and fertility: 47,XXY, 47,XYY, 47,XXX and 45,X/47,XXX That is not rare at all.
A nationwide Danish study found that Turner syndrome (where a girl has only one X chromosome instead of two) occurs in about 59 per 100,000 female births, while Klinefelter syndrome (where a boy has an extra X chromosome) occurs at about 57 per 100,000 male births. Triple X syndrome turned up at 11 per 100,000 females, and 47,XYY at 18 per 100,000 males.6PubMed Central. Changes in the cohort composition of turner syndrome and severe non-diagnosis of Klinefelter, 47,XXX and 47,XYY syndrome: a nationwide cohort study The striking finding was how many people with these conditions never get diagnosed. Only about 38% of people with Klinefelter syndrome, 13% with Triple X, and 18% with 47,XYY eventually receive a diagnosis during their lifetime.
This matters because most people with Klinefelter or Triple X syndrome look and feel unremarkably male or female. They may be taller than average or have subtle fertility issues, but they do not have ambiguous genitalia, and most would never describe themselves as intersex. Including them in a prevalence estimate alongside people born with genuinely ambiguous anatomy inflates the number dramatically. It is a defensible choice if you are interested in the full biological spectrum, but it muddies the water if you want to know how many babies are born with anatomy that puzzles the delivery team.
Androgen Insensitivity and Enzyme Deficiencies
Some of the most striking variations of sex development involve bodies that have one chromosomal sex but develop physical characteristics of the other. Androgen insensitivity syndrome (AIS) is a condition where a person has XY chromosomes but the body’s cells cannot respond to androgens like testosterone. In its complete form, a person with AIS develops female external genitalia, breast tissue at puberty, and a female body shape, despite having XY chromosomes and internal testes rather than ovaries. AIS is caused by mutations in the androgen receptor gene and ranges from complete to partial to mild, creating a wide phenotypic spectrum.7PubMed. Androgen insensitivity and the evolving genetic heterogeneity Complete AIS occurs in roughly 1 in 20,000 to 1 in 64,000 XY births, depending on the study.
Then there are enzyme deficiencies that block a specific step in hormone production. 5-alpha-reductase type 2 deficiency prevents the conversion of testosterone to dihydrotestosterone, the more potent androgen responsible for typical male external genital development. Children with this condition are often raised as girls because their genitalia appear female or ambiguous at birth, but at puberty a surge of testosterone can cause masculinization: voice deepening, muscle growth, and sometimes the descent of previously undescended testes. A global review identified 434 reported cases across 44 countries, with the largest clusters in Turkey, China, Italy, and Brazil. About 69% of those patients had been initially assigned female at birth.8PubMed Central. Integrative and Analytical Review of the 5-Alpha-Reductase Type 2 Deficiency Worldwide This condition is extremely rare in most populations but clusters in communities with high rates of consanguinity, where both parents are more likely to carry the same recessive gene variant.
Chimerism and Other Uncommon Pathways
One of the rarest pathways to an intersex body is tetragametic chimerism, which occurs when two fertilized eggs that would have become fraternal twins fuse into a single embryo early in development. If one embryo was destined to be male and the other female, the resulting person can end up with some cells carrying XX chromosomes and others carrying XY. Depending on how the cells distribute during development, this can produce mixed gonadal tissue or other intersex traits. A case report described intersexual twins resulting from tetragametic chimerism, calling it the first documented instance of this specific mechanism leading to intersexuality.9PubMed. Intersexual Twins due to Tetragametic Chimerism The rarity of such cases underscores that while the biological mechanisms allowing mixed-sex development exist, the conditions that trigger them are unusual.
Why the Terminology Shifted
You will not find the word “hermaphrodite” in a modern clinical chart. In 2006, an international consensus conference proposed replacing the older terms (“hermaphrodite,” “pseudohermaphrodite,” “intersex”) with the umbrella label “disorders of sex development,” or DSD.10PubMed. Consensus statement on terminology and management: disorders of sex development A European survey found that 100% of responding clinical centers adopted the new terminology, and there was a measurable drop in the use of older terms in published medical literature.11PubMed. Consequences of the Chicago consensus on disorders of sex development (DSD): current practices in Europe
The shift was partly practical and partly political. “Hermaphrodite” is biologically inaccurate for most people it was applied to, since true simultaneous production of both eggs and sperm does not occur in humans. “Pseudohermaphrodite” was confusing and felt pejorative. And the old terminology lumped together people whose conditions shared very little in common medically. The new classification sorts conditions by their underlying mechanism: sex chromosome DSD (like Turner or Klinefelter), 46,XY DSD (like AIS or 5-alpha-reductase deficiency), and 46,XX DSD (like congenital adrenal hyperplasia). Not everyone in the intersex community embraces “DSD” either, since some feel “disorder” pathologizes natural variation, but it remains the standard in clinical settings.
The Surgery Debate
For decades, the standard clinical approach to a baby born with ambiguous genitalia was to assign a sex quickly and perform surgery to make the anatomy match. The reasoning was that children needed a clear gender and consistent-looking body to develop normally. This practice took hold in an era when physicians held enormous authority over such decisions, and parental consent was given in a context far more deferential to medical expertise than exists today.12PubMed. Did Bioethics Matter? A History of Autonomy, Consent, and Intersex Genital Surgery
The tide has been turning, slowly. The 2006 consensus statement recommended more caution, and the European survey that followed showed that the majority of centers had either reduced or held steady the number of clitoroplasties they performed, with only about 3% reporting an increase.11PubMed. Consequences of the Chicago consensus on disorders of sex development (DSD): current practices in Europe Advocacy organizations have pushed to delay irreversible surgery until the person is old enough to participate in the decision. The debate is far from settled, but the direction of movement is toward more restraint.
Gender Identity and Outcomes
A common worry for families is whether a child with a DSD will be comfortable with the sex they are assigned at birth. The evidence suggests that most will. Studies consistently find that the large majority of people with DSDs develop a gender identity that matches their assigned sex. However, gender dysphoria, a persistent discomfort with one’s assigned sex, occurs in about 8% of people with DSD overall and between roughly 8.5% and 20% depending on the specific condition.13PubMed. Gender dysphoria associated with disorders of sex development That rate is considerably higher than in the general population.
The risk is not evenly distributed. People with 5-alpha-reductase deficiency and a related enzyme deficiency called 17-beta-hydroxysteroid dehydrogenase 3 deficiency show the highest rates of gender dysphoria, with some studies reporting rates up to 63%.13PubMed. Gender dysphoria associated with disorders of sex development This makes sense biologically: these are conditions where a child’s brain may have been exposed to male-typical hormone levels prenatally despite female-appearing anatomy, so an initial female sex assignment may feel wrong after puberty triggers further masculinization. By contrast, people with congenital adrenal hyperplasia, where XX individuals are exposed to excess androgens in utero, tend to have lower rates of gender dysphoria and are more likely to remain comfortable with a female assignment.14Revista Española de Endocrinología Pediátrica. Gender assignment and identity in DSD
Hermaphroditism in the Animal Kingdom
If humans are vanishingly rarely born with both types of gonadal tissue, the animal world takes a completely different approach to the question. Sequential hermaphroditism, where an individual changes sex during its lifetime, is a normal reproductive strategy in hundreds of fish species. Clownfish are born male and the dominant individual in a group transitions to female (protandry), while many wrasses and parrotfish do the opposite, starting female and becoming male (protogyny). A study comparing reproductive success across sex-changing fish species found that regardless of which direction the change goes, individuals produce more offspring and show greater variation in reproductive success in their second sex, confirming that the strategy is an adaptive response to social and ecological pressures rather than a developmental accident.15PubMed Central. Ecological and evolutionary consequences of alternative sex-change pathways in fish
Simultaneous hermaphroditism, where a single individual produces both eggs and sperm at the same time, is even more widespread if you look beyond vertebrates. Many snails, slugs, earthworms, and flatworms are simultaneous hermaphrodites. Some corals and sea bass species are too. In these organisms, having both reproductive functions at once is not a disorder; it is the default. The rarity of intersex conditions in humans reflects our evolutionary lineage as a species with strongly canalized, two-sex development rather than any fundamental impossibility. The genetic toolkit that allows other animals to develop both types of reproductive tissue exists in modified form in mammals, but it is typically locked into one pathway or the other very early in embryonic life.
Diagnostic Lab Practices and Emerging Concerns
Modern genetic testing has made it easier than ever to identify chromosomal and hormonal variations, but the way labs handle sex-related findings raises its own issues. Standard quality-control procedures in genetic laboratories often include a “sex check,” comparing the sex a patient reports against the sex chromosomes found in their sample. This step was designed to catch sample mix-ups, but it can inadvertently reveal a chromosomal variation the patient did not know about or flag transgender patients in ways that create discomfort in clinical settings.16PubMed Central. Policy and laboratory practice: How quality control procedures for genetic testing perpetuate biological essentialism and discrimination against transgender, gender diverse, and intersex people As genetic testing becomes routine for an ever-wider range of medical purposes, from cancer screening to pharmacogenomics, the number of people incidentally discovering a sex-chromosome variation is likely to grow. How labs communicate those findings, and whether those findings are even clinically relevant to the reason for testing, is an area where policy has not caught up with technology.